PID1 and COVID-19: In addition, some mito-DEGs were reversely altered in the AT2 and AT1 subsets (e.g., LRRK2, PID1, SOD2, CLIC4, and ERBB4) or showed altered expression in the AT2 or AT1 subset in patients with COVID-19 (Figures 4B, –D).